Rockwell Medical, Inc. announced that the Company entered into a three-year product purchase agreement with Centers for Dialysis Care, Inc. ("CDC"). CDC provides in-center dialysis, home dialysis, training, education support, and nutrition counseling to individuals with kidney disease and kidney failure. As part of this long-term, multi-million dollar product purchase agreement, which includes supply and purchasing commitments, Rockwell Medical will be the preferred supplier of liquid and dry acid and bicarbonate hemodialysis concentrates and related accessories to CDC and its nearly 20 facilities located throughout Northeastern Ohio.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 USD | +0.59% | +6.88% | -9.52% |
May. 14 | Transcript : Rockwell Medical, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Earnings Flash (RMTI) ROCKWELL MEDICAL Reports Q1 Revenue $22.7M, vs. Street Est of $21.7M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.52% | 49.92M | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Rockwell Medical Enters into 3-Year Product Purchase Agreement with Centers for Dialysis Care